calendar

4 catalysts · 2 phase iv trial initiation · 1 drug expiry · 1 patent expiry

★ save view ↓export CSV

next 91 dayslessmore

MonWedFri

view

agenda month

sort

soonest latest type sponsor alpha

TA: ophthalmology×TA: pulmonology×to 2026-04-24×clear all

type

phase iv trial initiation2
drug expiry1
patent expiry1

therapy area

Oncology9
Infectious Disease5

Dermatology

Week of Apr 20, 2026

›Apr 24, 2026patent expiry109d agoDaiichi Sankyo Co Ltd — laninamivir (Constraining Patent Expiry (Japan))laninamivir

Therapy area: Infectious Disease, Respiratory. Indication: Asthma, Influenzavirus A Infections, Influenzavirus B Infections

full page →laninamivir →source: globaldata

›Apr 24, 2026drug expiry109d agoDaiichi Sankyo Co Ltd — laninamivir (Drug Expiry (Japan))laninamivir

Therapy area: Infectious Disease, Respiratory. Indication: Asthma, Influenzavirus A Infections, Influenzavirus B Infections

full page →laninamivir →source: globaldata

›Apr 24, 2026phase iv trial initiation109d agoPeople's College of Medical Sciences & Research Centre — formoterol (Phase IV Trial Initiation)formoterol

Therapy area: Respiratory. Indication: Chronic Obstructive Pulmonary Disease (COPD)

full page →formoterol →source: globaldata

›Apr 24, 2026phase iv trial initiation109d agoDr Rajendra Prasad Centre for Ophthalmic Sciences — carboxymethylcellulose (Phase IV Trial Initiation)carboxymethylcellulose

Therapy area: Ophthalmology. Indication: Keratoconjunctivitis Sicca (Dry Eye), Unspecified Ophthalmological Disorders

full page →carboxymethylcellulose →source: globaldata